CC-BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2018; 22(02): 130-135
DOI: 10.1055/s-0037-1603921
Original Research
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Comparative Study Between Peristomal Patches in Patients with Definitive Tracheostomy

Liset Lansaat
Department of Head and Neck Surgery and Oncology, Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands
,
Bertram de Kleijn
Department of Otorhinolaryngology/Head and Neck Surgery, Universitair Medisch Centrum Groningen, Groningen, The Netherlands
,
Frans Hilgers
Department of Head and Neck Surgery and Oncology, Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands
Institute of Phonetic Sciences, University of Amsterdan, Amsterdan, The Netherlands
,
Bernard van der Laan
Department of Otorhinolaryngology/Head and Neck Surgery, Universitair Medisch Centrum Groningen, Groningen, The Netherlands
,
Michiel van den Brekel
Department of Head and Neck Surgery and Oncology, Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands
Institute of Phonetic Sciences, University of Amsterdan, Amsterdan, The Netherlands
Department of Maxillofacial Surgery, Academic Medical Center, University of Amsterdan, Amsterdan, The Netherlands
› Author Affiliations
Further Information

Publication History

15 February 2017

13 May 2017

Publication Date:
16 June 2017 (eFirst)

Abstract

Introduction To prevent or diminish pulmonary problems in laryngectomized patients, continuous use of a heat and moisture exchanger (HME) is recommended. Therefore, automatic speaking valves are also often combined with an HME to enable hands-free speech. In order to keep these devices in place, most commonly, peristomal patches are used.

Objective This prospective clinical 2 × 2 crossover study aims at assessing the added value of a new patch for HME application, the Provox StabiliBase OptiDerm (SBO). The device combines the stable and conical base of the Provox StabiliBase with the skin-friendlier hydrocolloid Provox OptiDerm (OD) patch.

Methods Thirty-two laryngectomized patients were included in this multicenter study. Participants were asked to compare SBO to OD, and to the patch they normally use. The primary outcome measure was patient preference.

Results Overall, 60% of the participants had preference for their normally used patch, 23% preferred the SBO and 17% indicated no preference. When comparing the SBO to the OD, 43% preferred the SBO, 40% the OD and 17% had no preference.

Conclusion Most patients preferred their normally used patch and SBO was favored by a subgroup. Provox StabiliBase OptiDerm seems to be a valuable addition to the existing patches and further increases patients' options for HME application.